Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00169741 · ClinicalTrials.gov registry record · NA

Renogram Study With Percutaneous Nephrolithotomy (PERC): Alterations in Renal Blood Flow as a Consequence of PERC

A NA study, sponsored by Indiana Kidney Stone Institute.

Completed
Registry status
NA
Development phase
4
Enrollment target

NCT00169741: Completed NA study, sponsored by Indiana Kidney Stone Institute.

NCT00169741 is a NA study that has completed, run by Indiana Kidney Stone Institute. The registered enrollment target is 4 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00169741, a NA study, has completed, sponsored by Indiana Kidney Stone Institute.

COMPLETED
Registry status
NA
Development phase
4 participants
Enrollment target

Study Summary

Patients with large or otherwise complex renal calculi are commonly treated by percutaneous nephrolithotomy (PNL; PERC). PERC requires the creation of an approximately 10 mm channel through the renal parenchyma, into the intra-renal collecting system, in order to effect stone fragmentation and extraction. Although the nephrostomy tract is confined to a small fraction of the renal parenchyma (approximately 1%), the trauma associated with the creation of the tract will affect blood flow and oxygen delivery to regions beyond the immediate site of injury. It is possible that this could result in a significant functional renal impairment. There are several reports describing the effect of PERC on renal function, but interpretation of these studies is difficult, due to a lack of uniformity in patient selection and variability in the timing of peri-operative evaluation. Recent data from the investigators' lab, obtained from a porcine model, suggest that, acutely, PERC causes a significant decrease in renal function as measured by para amino hippurate (PAH) clearance. The purpose of this study is to determine, in a rigorous and standardized fashion, the acute effects of PERC on renal function, as measured by nuclear renography.

Interventions

  • OTHER Renogram

Trial Details

FieldValue
Enrollment Target 4 participants
Start Date 2005-05
Est. Completion 2016-02
Phase NA
Indiana Kidney Stone Institute

16 total trials

What the finished NCT00169741 record still lists

NCT00169741 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 4 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).

The record links to 0 conditions, and to 1 intervention - of which Renogram is the first listed.

NCT00169741 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT00169741 about?

NCT00169741 is a clinical study titled "Renogram Study With Percutaneous Nephrolithotomy (PERC): Alterations in Renal Blood Flow as a Consequence of PERC". Patients with large or otherwise complex renal calculi are commonly treated by percutaneous nephrolithotomy (PNL; PERC). PERC requires the creation of an approximately 10 mm channel through the renal parenchyma, into the intra-renal collecting system, in order to effect stone fragmentation and extra...

What is the current status of trial NCT00169741?

This trial is currently completed. It is a NA study. The enrollment target is 4 participants. The study started on 2005-05. Estimated completion is 2016-02.

What interventions are being tested in trial NCT00169741?

The interventions under investigation include: Renogram (OTHER).

Who is sponsoring clinical trial NCT00169741?

This trial is sponsored by Indiana Kidney Stone Institute, which has 16 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT00169741's enrollment target sits among peer trials

4 1996th of 2000 higher than 5 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00169741, the US trial registry maintained by the National Library of Medicine. NCT00169741 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.